SC-41930 inhibits neutrophil infiltration of the cavine dermis induced by 12(R)-hydroxyeicosatetraenoic acid

Psoriasis is a disease state characterized by epidermal proliferation, neutrophil infiltration, along with release of the proinflammatory mediators leukotriene-B 4 (LTB 4) and 12(R)-hydroxyeicosatetraenoic acid [12(R)-HETE]. LTB 4 and 12(R)-HETE are chemoattractant to the neutrophil, the latter appr...

Full description

Saved in:
Bibliographic Details
Published inProstaglandins, leukotrienes and essential fatty acids Vol. 38; no. 3; pp. 169 - 172
Main Authors Fretland, D.J., Widomski, D.L., Shone, R.L., Penning, T.D., Miyashiro, J.M., Djuric, S.W.
Format Journal Article
LanguageEnglish
Published Kidlington Elsevier Ltd 01.12.1989
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Psoriasis is a disease state characterized by epidermal proliferation, neutrophil infiltration, along with release of the proinflammatory mediators leukotriene-B 4 (LTB 4) and 12(R)-hydroxyeicosatetraenoic acid [12(R)-HETE]. LTB 4 and 12(R)-HETE are chemoattractant to the neutrophil, the latter approximately 1000X less potent. LTB 4 and 12(R)-HETE are present in psoriatic scale, the latter in quantities so much greater than LTB 4 that it is proposed as a primary mediator of neutrophil infiltration in psoriasis. 12(R)-HETE, synthesized in optically pure form by a new, shorter route, was injected into the cavine dermis. At a dose of 25 μgm per intradermal site, 12(R)-HETE was a significant chemoattractant to the neutrophil (as assessed by dermal myeloperoxidase levels). SC-41930, 7-[3-(4-acetyl-3-methoxy-2-propylphenoxy)-propoxy]-3,4-dihydro-8-propyl-2H-1-benzopyran-2-carboxylic acid, given intragastrically inhibited 12(R)-HETE-induced neutrophil infiltration of the cavine dermis with an ED 50 value of 13.5 mg/kg. Compounds such as SC-41930 may well have utility for treating human psoriasis.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0952-3278
1532-2823
DOI:10.1016/0952-3278(89)90067-7